Entrada Therapeutics, Inc. today announced that it has entered into a securities purchase agreement with a group of investors for the purchase of 3,367,003 shares of common stock and pre-funded warrants to purchase up to 3,367,003 shares.
June 24, 2024
· 4 min read
